Ecolab Inc. filings document the public-company disclosures of a Delaware operating company whose common stock trades on the New York Stock Exchange under ECL. The filings cover operating and financial results, supplemental segment reporting, changes to reportable segment structure, capital-structure information and material-event reports.
Proxy and 8-K filings describe annual-meeting matters, board and executive-leadership changes, compensation and governance topics, and shareholder voting materials. Other disclosures address material agreements, restructuring and exit-cost matters associated with the One Ecolab initiative, business context for water, hygiene and infection prevention operations, and the company’s service footprint across multiple customer industries.
A holder associated with Ecolab Inc. (ECL) has filed a notice of intent to sell 613 shares of common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney LLC – Executive Services on the NYSE, reflects an aggregate market value of $184,323.
The securities were acquired on 02/13/2026 via an employee stock option exercise for 950 shares, executed as a broker-assisted cashless exercise on the same date. The filing notes that total common shares outstanding were 283,235,653 as of this transaction context.
A shareholder of ECL has filed a Rule 144 notice to sell 7,900 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 02/12/2026.
The filing lists an aggregate market value of 2,398,045 for these shares and notes 283,235,653 shares outstanding. The seller acquired the stock over time via employee stock option exercises and performance-based restricted stock unit vesting, including transactions dated 12/07/2012, 02/20/2013, 02/19/2025, and 02/26/2025.
Ecolab Inc. reported a record fourth quarter and full year 2025, with Q4 net sales of $4.20 billion, up 5%, and reported diluted EPS of $1.98. Adjusted diluted EPS was $2.08, up 15% from $1.81, driven by organic sales growth, margin expansion and productivity gains.
For 2025, net sales reached $16.08 billion and adjusted diluted EPS was $7.53, up from $6.65. All major segments grew sales, with particularly strong operating income growth in Global Institutional & Specialty, Pest Elimination and Life Sciences.
Ecolab expanded its One Ecolab productivity and restructuring initiative, now expecting annualized savings of about $325 million by 2027, alongside anticipated pre-tax charges of approximately $425 million, mainly severance. For 2026, the company targets adjusted diluted EPS of $8.43–$8.63, an increase of 12%–15%, on reported sales growth of 7%–9% and 100–150 basis points of operating margin expansion.
Ecolab Inc. director John J. Zillmer reported acquiring 128 shares of Ecolab common stock on 12/31/2025 at a price of $0 per share. After this transaction, he beneficially owned 47,591.24 shares held directly. The filing notes that this total includes 37.38 shares obtained through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. No derivative securities transactions were reported.
Ecolab Inc. director Julie Whalen reported an acquisition of company stock in an insider transaction dated 12/31/2025. The Form 4 shows she acquired 128 shares of Ecolab common stock, coded as an acquisition and reported at a price of $0 per share, indicating this was likely a grant or award rather than an open‑market purchase. Following this transaction, her holdings are reported as directly owned. The filing is made by a single reporting person and is signed by an attorney‑in‑fact on her behalf.
Ecolab Inc. director Suzanne M. Vautrinot reported acquiring additional company stock through an equity compensation plan. On 12/31/2025, she acquired 128 shares of Ecolab common stock at a stated price of $0, increasing her holdings to 11,490.79 shares held directly after the transaction.
The reported balance includes 20.08 shares obtained through the dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, which uses dividends to purchase additional shares. No derivative securities transactions were reported in this filing.
Ecolab Inc. director reports additional share acquisition
A director of Ecolab Inc. reported acquiring 128 shares of Ecolab common stock on 12/31/2025 at a stated price of $0, reflecting stock-based compensation rather than an open-market purchase. After this transaction, the director beneficially owns 25,175.69 shares of Ecolab common stock. This total includes 56.58 shares received through the dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan. The filing is made as a Form 4 by one reporting person in the capacity of director.
Ecolab Inc. director reports routine stock acquisition
A director of Ecolab Inc. (ECL) reported acquiring 128 shares of common stock on 12/31/2025 at a stated price of $0, increasing their beneficial ownership to 6,470.89 shares held directly. The total includes 14.73 shares obtained through a dividend reinvestment feature under an Ecolab non-employee director stock and deferred compensation plan. This filing documents the updated ownership position but does not describe any broader corporate or financial changes at Ecolab.
Ecolab Inc. director reports stock acquisition
A director of Ecolab Inc. (ECL) reported acquiring 128 shares of common stock on 12/31/2025 at a stated price of $0, as shown in a Form 4 insider trading report. Following this transaction, the director beneficially owns 10,322.58 shares directly. The filing notes that this total includes 18.23 shares obtained through the dividend reinvestment feature of Ecolab’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
Ecolab Inc. director David W. MacLennan reported acquiring additional Ecolab common stock on 12/31/2025. He obtained 128 shares at a price of $0 and 43.85 shares at a price of $263.675 per share, increasing his directly held position to 23,224.05 shares of Ecolab common stock. The filing also shows indirect ownership of 3,500 shares through the Kathleen F. MacLennan Revocable Trust and 709 shares through sibling trusts. The reported total includes 17.12 shares acquired via the dividend reinvestment feature of Ecolab’s 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.